|Bid||180.00 x 1100|
|Ask||224.50 x 800|
|Day's range||211.99 - 217.26|
|52-week range||167.42 - 241.86|
|Beta (5Y monthly)||1.42|
|PE ratio (TTM)||36.33|
|Earnings date||08 Feb 2024 - 12 Feb 2024|
|Forward dividend & yield||N/A (N/A)|
|1y target est||225.37|
IQVIA (IQV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
INNOVATION PARK, N.C., November 29, 2023--IQVIA™ (NYSE:IQV), a leading global provider of data, analytics, technology solutions and services to the life sciences industry, today announced that IQVIA Digital Enablement has been named a PM360 Trailblazer 2023 Company of the Year in the Supplier/Vendor category.
INNOVATION PARK, N.C., November 21, 2023--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Evercore Annual HealthCONx Conference in Miami on Wednesday, November 29, 2023 at 10:50 a.m. ET.